Efficacy and Safety of Simvastatin-ezetimibe Combination Therapy Among Patients With SLE

Summary

This is a randomized single-blind trial. This study aimed to determine if intensive lipid-lowering therapy (simvastatin-ezetimibe combination therapy) could reduce the progression of atherosclerosis effectively and safely among SLE patients with carotid artery intima thickening. The study results were expected to be helpful for SLE patients in preventing atherosclerosis.

Timeline

Start

2015-04

Primary completion

2016-10

Completion

2016-12

Drugs

Indications